2.1 Study design In this prospective, double-blind, cross-over interventional study, patients were randomized in balanced blocks (1:1) into two groups: Sequence 1, HA-first, received the control product (containing only hyaluronic acid 0.2%) for 4 weeks, followed by a 1-week washout, and then the experimental product (hyaluronic acid 0.2% + butyroyl glutathione 0.4%) for 4 weeks
Another set of genes known to raise ovarian cancer risks are the mismatch Permanent link to this article: ICARE Newsletter Summer 2014 Is There a Higher Risk of Prostate Cancer in Individuals with Lynch Syndrome
Insurance Cancellations, Refunds, and Commitment Terms Month-to-month plan
doi: 10.3389/fncel.2024.1405782 Received 23 March 2024 Accepted 26 July 2024 Published 07 August 2024 Volume 18 - 2024 Edited by Abdullah Shaito, Qatar University, Qatar Reviewed by Michael John Hylin, Southern Illinois University Carbondale, United States Yuxiang Fei, China Pharmaceutical University, China Alexander V
doi: 10.1002/advs.202201734 103 HuangHXieWHuDHeXLiRZhangXet al
However, there was a significant 40 and 34% decrease in ovarian cancer incidence for the highest versus lowest quintile for kaempferol and luteolin intake, respectively [158]